Daniel Willingmyre,

Stability and Data Analytics, Vir Biotechnology, Inc,

---

Dan Willingmyre has over 20 years of industry experience with expertise in cell-based assay development, large molecule stability strategy, specification setting, and statistics. His experience in these areas has covered large molecule programs from the research phase through commercial life-cycle management.  Dan has applied phase appropriate and prior-knowledge based strategies to establish risk-based approaches to various aspects of product development including expiry justification, comparability evaluations, critical reagent qualifications, method bridging and specification justification.